Ann: CBCF funding to support deoxymab brain cancer development, page-14

Well said Matty.....if you have the patience to stick around and hold while the SP is doing nothing, you will be rewarded in spades in the not too distant future IMO.

I just remind myself that this company has an antibody that is capable of crossing the blood brain barrier and this is HUGE in the medical world. I can't believe that there isn't at least one big pharma company that is ready to pounce at the appropriate time and that is most likely once we get a big tick on the engineering.

My personal opinion is that we get into a collaboration with one of these guys well before we even get into the clinic.

Please DYOR and GLTAH....